LUDOVISI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 2.499
AS - Asia 1.115
EU - Europa 1.113
SA - Sud America 253
AF - Africa 27
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.013
Nazione #
US - Stati Uniti d'America 2.449
SG - Singapore 648
RU - Federazione Russa 351
IE - Irlanda 324
BR - Brasile 213
DE - Germania 168
CN - Cina 125
VN - Vietnam 115
HK - Hong Kong 111
IT - Italia 54
FI - Finlandia 44
GB - Regno Unito 40
FR - Francia 32
CA - Canada 28
IN - India 20
BD - Bangladesh 18
NL - Olanda 17
CZ - Repubblica Ceca 15
MX - Messico 15
PL - Polonia 13
TR - Turchia 13
AR - Argentina 12
ZA - Sudafrica 12
BE - Belgio 11
JP - Giappone 11
SE - Svezia 9
AT - Austria 8
CO - Colombia 7
EC - Ecuador 6
IQ - Iraq 6
PK - Pakistan 6
IL - Israele 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
ES - Italia 4
LT - Lituania 4
MA - Marocco 4
UY - Uruguay 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
JO - Giordania 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
KR - Corea 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
UA - Ucraina 2
BG - Bulgaria 1
CG - Congo 1
EG - Egitto 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.013
Città #
Dallas 520
Chandler 411
Singapore 362
Dublin 322
San Jose 246
Ashburn 171
Santa Clara 113
Hong Kong 111
The Dalles 67
Munich 59
Boardman 58
Los Angeles 51
New York 51
Moscow 48
Bremen 40
Lawrence 40
Princeton 40
Ho Chi Minh City 37
Wilmington 36
Hanoi 29
Cedar Knolls 28
Columbus 28
Council Bluffs 25
Falkenstein 25
São Paulo 22
Beijing 21
Helsinki 19
Turku 17
Lauterbourg 16
Brooklyn 13
San Francisco 13
Brno 12
Toronto 12
Warsaw 12
Brussels 11
Düsseldorf 11
Frankfurt am Main 10
Tokyo 10
Belo Horizonte 9
Johannesburg 9
Manchester 9
Poplar 9
Rome 9
Stockholm 9
Amsterdam 8
Denver 8
Hefei 8
Lappeenranta 8
Montreal 8
Brasília 7
Chennai 7
Chicago 7
Da Nang 7
Atlanta 6
Bogotá 6
Boston 6
Guangzhou 6
London 6
L’Aquila 6
Norwalk 6
Vienna 6
Istanbul 5
Mexico City 5
Phoenix 5
Washington 5
Baku 4
Charlotte 4
Guarulhos 4
Guayaquil 4
Haiphong 4
Houston 4
Montevideo 4
Mumbai 4
Orem 4
Porto Alegre 4
Rio de Janeiro 4
Tashkent 4
Amman 3
Ankara 3
Berlin 3
Culver City 3
Curitiba 3
Dhaka 3
Fremont 3
Maracaibo 3
Miami 3
Minneapolis 3
Querétaro 3
Recife 3
Santo André 3
Seattle 3
Shanghai 3
Sorocaba 3
Tappahannock 3
Tel Aviv 3
Abidjan 2
Asunción 2
Baghdad 2
Belgrade 2
Betim 2
Totale 3.419
Nome #
Microsatellite Instability and Myometrial Infiltration in Low-Grade Endometrial Cancer: A Focus on MMR Heterodimer Dysfunction by a Retrospective Multicentric Italian Study 177
Inflammatory Indices vs. CA 125 for the Diagnosis of Early Ovarian Cancer: Evidence from a Multicenter Prospective Italian Cohort 151
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 140
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 136
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 135
Sex ratio at birth: causes of variation and narrative review of literature 133
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 125
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival 120
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: A pilot study 115
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 114
Synchronous ovarian and uterine tumours, case report of an unusual association 110
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 107
Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy 104
Uterine perforation and small bowel incarceration 11 months after dilatation and curettage: sonographic and surgical findings 102
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 97
Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay 96
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 95
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 95
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients 95
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer 95
Imaging in gynecological disease (1): Ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 93
Imaging in gynecological disease (9): Clinical and ultrasound characteristics of tubal cancer 93
Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging 93
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: The CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group 93
Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: A prospective study 93
Ultrasound features of different histopathological subtypes of borderline ovarian tumors 92
Sonographic characteristics of ovarian Leydig cell tumor 91
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy 91
Ultrasound appearance of breast cancer metastatic to uterine leiomyoma 90
Ultrasound and color power Doppler in the detection of metastatic omentum: A prospective study 89
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 89
Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer 88
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 87
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer 86
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study 83
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer 82
A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer 82
Clinical utility of trabectedin for the treatment of ovarian cancer: Current evidence 81
Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer 80
Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: Accuracy in patients submitted to neoadjuvant treatments 80
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: A phase II study 80
Ovarian cancer arising in endometrioid cysts: Ultrasound findings 78
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 77
Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature 77
Ultrasound examiners' ability to describe ovarian cancer spread using preacquired ultrasound videoclips from a selected patient sample with high prevalence of cancer spread 74
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 74
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy 74
The role of sonographic examination in the follow-up of gynecological neoplasms 72
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications 71
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 70
Diagnosis, management and outcomes of incarceration or intussusception of Fallopian tubes following uterine perforation after vacuum aspiration or dilatation and curettage of the uterine cavity: a systematic review of the literature 69
Re: Factors affecting visualization of postmenopausal ovaries: Descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) 67
In reply 66
Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: A pilot study 65
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma [1] 63
How family functioning shapes prenatal bonding: a mediation analysis of depressive symptoms and maternal–fetal attachment 3
Totale 5.178
Categoria #
all - tutte 22.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022320 0 0 0 0 0 42 6 11 14 49 16 182
2022/20231.068 87 99 78 94 77 72 43 59 414 13 24 8
2023/2024233 29 21 32 16 33 41 2 10 1 20 12 16
2024/20251.248 26 23 76 81 167 117 141 88 245 82 115 87
2025/20262.309 123 168 433 369 243 164 270 67 217 255 0 0
Totale 5.178